• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.57% Nasdaq Up 2.12%

    More On ALSE

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Alseres Pharmaceuticals, Inc. (ALSE)

    -Other OTC
    65.00 0.00(0.00%) Jun 7
    Prev Close:65.00
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:0.691682
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:65.00 - 500.00
    Volume:0
    Avg Vol (3m):0
    Market Cap:398.26K
    P/E (ttm):N/A
    EPS (ttm):-0.03
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALSE 0.00%398.26K
    ACORUp 3.39%1.17B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alseres Pharmaceuticals, Inc., a biotechnology company, together with its subsidiaries, focuses on developing therapeutic and diagnostic products primarily for disorders in the central nervous system. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback